Title:

PRIMARY BRAIN CANCER MARKET OVERVIEW

Price:$2,720.00
Publication Date:Mar 28, 2008
Source:DATAMONITOR PREMIUM REPORTS
Brief Excerpt:...Ark Therapeutics Cerepro (sitimagene ceradenovec) ## Peregrine Pharmaceuticals s Cotara (###I-chTNT-#/B) ## YM Biosciences/Biocon Biopharmaceuticals Theraloc (nimotuzumab) ## NeoPharm s cintredekin besudotox ## ...
Length:35 Pages (34 Billable Pages)
Geographic Region:MULTINATIONAL
Industry:HEALTH CARE, MISCELLANEOUS SERVICE, PHARMACEUTICALS
Non-Billable Page Numbers:2
Format:Adobe Acrobat Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
Primary brain cancer market overview11
ABOUT DATAMONITOR21
PRIMARY BRAIN CANCER 731
APPENDIX 3132
LIST OF FIGURES51
LIST OF TABLES61
PRIMARY BRAIN CANCER71
Overview of primary brain cancer73
Unmet need in primary brain cancer101
UNMET NEEDS112
Pipeline overview1314
Forecasts to 2016272
Datamonitor drug assessment summary291
Commercial attractiveness (%)291
Clinical attractiveness (%)291
Satisfaction of unmet needs301
APPENDIX311
List of abbreviations312
Methodology332
Commercial attractiveness (%)351
Clinical attractiveness (%)351
Tables
TitleStarting PageNumber of Pages
OF CONTENTS31

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $2,720.00

TF Market Research

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top con sulting, market research and business publishing sources. The service is updated daily.

  about us contact us public company index private company index pcan widget your privacy rights terms & conditions